Verition Fund Management LLC Astrazeneca PLC Put Options Transaction History

Verition Fund Management LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2021 Feb 14, 2022	SELL	$54.02 - $63.83 $804,898 - $951,067	-14,900 Reduced 6.06%	230,800 $13.4 Million
Q3 2021 Nov 15, 2021	BUY	$55.56 - $60.79 $1.98 Million - $2.17 Million	35,700 Added 17.0%	245,700 $14.8 Million
Q2 2021 Aug 16, 2021	SELL	$48.42 - $60.18 $7.07 Million - $8.79 Million	-146,100 Reduced 41.03%	210,000 $12.6 Million
Q1 2021 May 18, 2021	BUY	$47.16 - $54.44 $4.16 Million - $4.8 Million	88,200 Added 32.92%	356,100 $17.7 Million
Q4 2020 Feb 16, 2021	BUY	$48.52 - $58.02 $13 Million - $15.5 Million	267,900 New	267,900 $13.4 Million

1,333

490M

4.99M

3.19M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $241B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

Stay updated on Verition Fund Management LLC with notifications on news.